Effect of Medication Co-payment Vouchers on P2Y(12) Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial

IMPORTANCE: Despite guideline recommendations, many patients discontinue P2Y(12) inhibitor therapy earlier than the recommended 1 year after myocardial infarction (MI), and higher-potency P2Y(12) inhibitors are underutilized. Cost is frequently cited as an explanation for both of these observations....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Wang, Tracy Y., Kaltenbach, Lisa A., Cannon, Christopher P., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cohen, David J., Bhandary, Durgesh, Khan, Naeem D., Anstrom, Kevin J., Peterson, Eric D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583585/
https://ncbi.nlm.nih.gov/pubmed/30620370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.19791
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados